Please assess the completion status of the following clinical trial:

Trial Title: Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Completed NK-104-304 (NCT 00309738)~* Hypercholesterolemia or combined dyslipidemia~* 2 or more risk factors for coronary heart disease (CHD)~Exclusion Criteria:~* Withdrawn or terminated from NK-104-304 (00309738)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pitavastatin 4 mg (Type: EXPERIMENTAL): Pitavastatin 4 mg once daily
- Simvastatin 40mg/80mg (Type: ACTIVE_COMPARATOR): Simvastatin 40 mg or 80 mg once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).